TREX1 AS A MARKER FOR LUPUS ERYTHEMATOSUS
    2.
    发明申请
    TREX1 AS A MARKER FOR LUPUS ERYTHEMATOSUS 审中-公开
    TREX1作为LUPUS ERYTHEMATOSUSUS的标记

    公开(公告)号:US20100104579A1

    公开(公告)日:2010-04-29

    申请号:US12442762

    申请日:2007-07-19

    Abstract: The present invention relates a method of diagnosing lupus erythematosus or related autoimmune diseases in a human, said method comprising at least one of detecting a genetic variant, a mutation or polymorphism in the gene encoding for TREX1, detecting a change in the biochemical activity of TREX1, and detecting a change in the expression of the gene encoding for TREX1. The present invention further relates to the use of TREX1 for therapy and as a target for new therapeutic approaches.

    Abstract translation: 本发明涉及一种诊断人类红斑狼疮或相关自身免疫疾病的方法,所述方法包括检测编码TREX1的基因的遗传变异,突变或多态性中的至少一种,检测TREX1的生化活性的变化 ,并检测编码TREX1的基因的表达变化。 本发明还涉及TREX1在治疗中的用途以及作为新治疗方法的靶标。

Patent Agency Ranking